A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients

被引：0
|
作者：
Begoña Pineda
Angel Diaz-Lagares
José Alejandro Pérez-Fidalgo
Octavio Burgués
Inés González-Barrallo
Ana B. Crujeiras
Juan Sandoval
Manel Esteller
Ana Lluch
Pilar Eroles
机构：
[1] Biomedical Research Institute (INCLIVA),Department of Physiology, Faculty of Medicine
[2] University of Valencia,Present Address: Cancer Epigenomics, Translational Medical Oncology (Oncomet)
[3] Centro de Investigacion Biomedica en Red Cancer (CIBERONC),Oncology Department
[4] Cancer Epigenetics and Biology Program (PEBC),Pathology Department
[5] Bellvitge Biomedical Research Institute (IDIBELL),Present Address: Laboratory of Epigenomics in Endocrinology and Nutrition
[6] Health Research Institute of Santiago (IDIS),Biomarkers and Precision Medicne Unit (UByMP)
[7] University Clinical Hospital of Santiago (CHUS/SERGAS),Physiological Sciences Department, School of Medicine and Health Sciences
[8] CIBERONC,undefined
[9] Hospital Clínico Universitario de Valencia,undefined
[10] Hospital Clínico Universitario de Valencia,undefined
[11] Instituto de Investigacion Sanitaria (IDIS),undefined
[12] Complejo Hospitalario Universitario de Santiago (CHUS),undefined
[13] Santiago de Compostela University (USC) and CIBER Fisiopatologia de la Obesidad y Nutricion (CIBERobn),undefined
[14] Instituto de Investigación Sanitaria La Fe (IISLaFeValencia),undefined
[15] University of Barcelona (UB),undefined
[16] Institució Catalana de Recerca i Estudis Avançats (ICREA),undefined
[17] Institució Catalana de Recerca i Estudis Avançats (ICREA),undefined
[18] COST action,undefined
来源：
Clinical Epigenetics | 2019年 / 11卷
关键词：
Triple-negative breast cancer; Prediction; Epigenetic signature;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients
    Pineda, Begona
    Diaz-Lagares, Angel
    Alejandro Perez-Fidalgo, Jose
    Burgues, Octavio
    Gonzalez-Barrallo, Ines
    Crujeiras, Ana B.
    Sandoval, Juan
    Esteller, Manel
    Lluch, Ana
    Eroles, Pilar
    [J]. CLINICAL EPIGENETICS, 2019, 11 (1)
  • [2] A gene signature predicts response to neoadjuvant chemotherapy in triple-negative breast cancer patients
    Zheng, Tianzhi
    Pang, Zhiyuan
    Zhao, Zhao
    [J]. BIOSCIENCE REPORTS, 2019, 39
  • [3] Gene signature-based prediction of triple-negative breast cancer patient response to Neoadjuvant chemotherapy
    Zhao, Yanding
    Schaafsma, Evelien
    Cheng, Chao
    [J]. CANCER MEDICINE, 2020, 9 (17): : 6281 - 6295
  • [4] Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer
    Mohamed Omar
    Pier Vitale Nuzzo
    Francesco Ravera
    Sara Bleve
    Giuseppe Nicolò Fanelli
    Claudio Zanettini
    Itzel Valencia
    Luigi Marchionni
    [J]. Journal of Translational Medicine, 21
  • [5] Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer
    Omar, Mohamed
    Nuzzo, Pier Vitale
    Ravera, Francesco
    Bleve, Sara
    Fanelli, Giuseppe Nicolo
    Zanettini, Claudio
    Valencia, Itzel
    Marchionni, Luigi
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [6] A novel prognostic two-gene signature for triple negative breast cancer
    Alsaleem, Mansour A.
    Ball, Graham
    Toss, Michael S.
    Raafat, Sara
    Aleskandarany, Mohammed
    Joseph, Chitra
    Ogden, Angela
    Bhattarai, Shristi
    Rida, Padmashree C. G.
    Khani, Francesca
    Davis, Melissa
    Elemento, Olivier
    Aneja, Ritu
    Ellis, Ian O.
    Green, Andrew
    Mongan, Nigel P.
    Rakha, Emad
    [J]. MODERN PATHOLOGY, 2020, 33 (11) : 2208 - 2220
  • [7] The response to neoadjuvant chemotherapy and prognosis of triple-negative breast cancer patients.
    Nakano, E.
    Hojo, T.
    Masumura, K.
    Kikuyama, M.
    Akashi, S.
    Kinoshita, T.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 337S - 337S
  • [8] Androgen Receptor Status and Prediction of Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer
    Stoos, Catherine
    Huggins-Puhalla, Shannon
    Dabbs, David
    Bhargava, Rohit
    [J]. LABORATORY INVESTIGATION, 2016, 96 : 74A - 74A
  • [9] Androgen Receptor Status and Prediction of Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer
    Stoos, Catherine
    Huggins-Puhalla, Shannon
    Dabbs, David
    Bhargava, Rohit
    [J]. MODERN PATHOLOGY, 2016, 29 : 74A - 74A
  • [10] Response and prognosis of taxanes and anthracyclines neoadjuvant chemotherapy in patients with triple-negative breast cancer
    Wu, Jiannan
    Li, Shunrong
    Jia, Weijuan
    Su, Fengxi
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (10) : 1505 - 1510
12345